M&A Capital Protection & High-Stakes Due Diligence
Protecting $127M in committed capital for a Diversified GCC Conglomerate
SAR 15M unrecorded exposure identified — $127M capital defended — Acquisition terms restructured prior to close
Governance design, IPO readiness, whistleblowing, ethics, and board oversight work.
5 engagements mapped to this area, presented as operational outcomes rather than framework slogans.
Case studies are abstracted where required to protect client and employer confidentiality while preserving the actual decision pattern and business consequence.
Each entry is framed around mandate, intervention, and commercial or governance consequence rather than generic control language.
Protecting $127M in committed capital for a Diversified GCC Conglomerate
SAR 15M unrecorded exposure identified — $127M capital defended — Acquisition terms restructured prior to close
Delivering a clean roadmap for a High-Growth F&B Technology Platform
Zero material weaknesses on initial ICFR audit — 175+ controls codified — Board and Audit Committee governance operationalized for prospectus
Coordinated ICOFR and regulatory submissions for KSA healthcare subsidiary.
Successful governance structuring for parallel market listing.
Designed email-based reporting and investigation protocols from scratch.
Uncovered SAR 12M procurement tender collusion within months of launch.
Engineered confidential intake channels, investigative playbooks, and Audit Committee reporting protocols.
Full ethics governance deployed across 7 operating countries with case tracking integrated.
The useful conversation starts with mandate, constraint, risk posture, and stakeholder reality. Everything else follows from that.
Discuss a Mandate